Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001764936 | SCV001989469 | uncertain significance | not provided | 2020-02-11 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |
Labcorp Genetics |
RCV002074006 | SCV002370614 | likely benign | Tuberous sclerosis 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004008995 | SCV004815932 | uncertain significance | Tuberous sclerosis syndrome | 2024-01-11 | criteria provided, single submitter | clinical testing | This variant causes a T to G nucleotide substitution at the -11 position of intron 19 of the TSC1 gene. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with tuberous sclerosis complex in the literature. This variant has been identified in 1/251422 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |